盈大地產(00432.HK)擬對2022年到期7億美元4.75釐擔保票據提出收購要約
格隆匯6月7日丨盈大地產(00432.HK)公佈,公司邀請由PCPD Capital Limited(發行人)發行及由公司無條件及不可撤回擔保的於2022年到期7億美元4.75釐的擔保票據的合資格持有人提呈任何及所有票據以供公司現金購買。收購要約將於2021年6月7日開始,並將於2021年6月16日下午4時正截止。公司根據收購要約購買的該等票據將由公司註銷。
提出收購要約(除其他目的外)旨在優化公司資產負債表架構,尤其是公司正尋求對未償還的該等票據進行再融資,將長期融資率鎖定於當前水平,並延長其負債的債務期限。發行人及公司擬發行新票據,其所得款項可用作為收購要約所需的資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.